To that end, the goals of the coalition are as follows:
The Coalition’s unique composition and pre-competitive nature lends itself well to hosting a monthly meeting among stakeholders committed to accelerating a cure for celiac disease. Primary objectives for 2025-2026 are:
We are proud to report that in May of 2024 the Beyond Celiac Coalition had a collaborative meeting with the FDA to discuss approaches to making therapeutic trials for celiac disease more patient-centric while maintaining scientific rigor. Read more about our meeting with the FDA.
Since 2003, Beyond Celiac has been the leading patient advocacy and research-driven celiac disease organization working to drive diagnosis, advance research and accelerate the discovery of new treatments and a cure.
Beyond Celiac has brought together members of academia, key opinion leaders, government agencies, and pharmaceutical, biotech and diagnostic companies to identify and address significant roadblocks to the diagnosis and treatment of celiac disease.
There are various membership tiers in our Coalition structure, each offering varying benefits. The Beyond Celiac Coalition is operated and funded by annual membership dues, with projects funded from supplemental funds industry members provide. Participation in individual projects is offered to all members. Individual project costs, principally event venue, external support and/or travel for academic members are agreed upon and shared equally among all industry member organizations participating in those projects.
To learn more about membership opportunities, contact our director of corporate partnerships Deanne Field at [email protected]
Opt-in to stay up-to-date on the latest news.
Yes, I want to advance research No, I'd prefer not to
